Enveric Biosciences, Inc. is a biotechnology company. Co. is engaged in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety and addiction disorders. Co., through Psybrary has created a robust intellectual property (IP) portfolio of new chemical entities for specific mental health indications. Its lead program, the EVM201 Series, comprises synthetic prodrugs of the active metabolite, psilocin. It is developing the first product from the EVM201 Series, EB-002, for the treatment of psychiatric disorders. We show 21 historical shares outstanding datapoints in our ENVB shares outstanding history coverage, used to compute ENVB market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ENVB market cap history over the course of time is important for investors
interested in comparing ENVB's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ENVB versus a peer is one thing; comparing
ENVB market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ENVB can fluctuate over the course of history.
With this page we aim to empower investors researching ENVB by allowing them to research the ENVB market cap history. |
Free ENVB Email Alerts:
Video: The Importance of Market Cap
